tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Stephanie Davis, 132 are a BUY (58.67%), 76 are a HOLD (33.78%), 17 are a SELL (7.56%).
Analyst Stephanie Davis, carries an average stock price target met ratio of 79.13% that have a potential upside of 19.44% achieved within 180 days. Previously, Stephanie Davis worked at LEERINK.
Stephanie Davis’s has documented 423 price targets and ratings displayed on 32 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on DGX, Quest Diagnostics at 30-Jan-2025.
Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 3/31/2022. The price target of $29 was fulfilled within 1 day with a profit of $2.64 (10.02%) receiving and performance score of 100.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5.75
5 months 1 days ago
(07-Jan-2025)
4/12 (33.33%)
$1.71 (42.33%)
54
Hold
$7.03
$0.01 (0.14%)
$8
5 months 1 days ago
(07-Jan-2025)
4/10 (40%)
$0.17 (2.48%)
139
Hold
$16
5 months 1 days ago
(07-Jan-2025)
2/3 (66.67%)
$1.01 (6.74%)
79
$5
$-2.02 (-28.77%)
$6
5 months 23 days ago
(16-Dec-2024)
10/13 (76.92%)
$1.6 (47.06%)
44
Hold
$6
$-1.02 (-14.53%)
$7
7 months 29 days ago
(10-Oct-2024)
10/11 (90.91%)
$2.21 (58.31%)
70
Which stock is Stephanie Davis is most bullish on?
What Year was the first public recommendation made by Stephanie Davis?
